EMPOWERING MYELOMA ADVOCACY ACROSS EUROPE     

Skip to content
Myeloma Patients EuropeMyeloma Patients Europe
Search:
  • About us
  • Contact us
Superior MPE
Myeloma Patients Europe
Myeloma Patients EuropeMyeloma Patients Europe
  • Myeloma and AL Amyloidosis
    • Multiple Myeloma
    • About AL amyloidosis
  • What we do
    • Member and patient community programmes
      • MPE Masterclass
      • Scholarship programme
      • Myeloma CABs
      • MPE Myeloma and AL amyloidosis Community Taskforce
      • Advocate Development Programme
      • Reasonable Agreements between Patient Advocates and Pharmaceutical Companies (RAPP)
      • COVID-19
    • Research
      • Patient Evidence
      • Horizon Europe
      • IMI
    • Access
      • Access to myeloma treatment
      • CEE workgroup on Access
      • Myeloma Trial Navigator
  • Educational resources
    • Educational clips
    • Webinars
    • Q&As
    • Toolkits
    • Factsheets
    • Conference reports
    • Patient guides
  • European Myeloma Day
  • News

Privacy Policy

Cookies Policy

Facebook page opens in new windowTwitter page opens in new windowYouTube page opens in new windowLinkedin page opens in new window

EMPOWERING MYELOMA ADVOCACY ACROSS EUROPE

  • About MPE
    • Our members
    • Our board and staff
    • Medical Advisory Commitee
    • Our funding
    • Get involved in MPE activities
    • Become a MPE member
  • Contact us
  • Myeloma and AL Amyloidosis
    • About myeloma
      • What is myeloma?
      • What causes myeloma?
      • Coping with a myeloma diagnosis
      • Early diagnosis and smoldering myeloma
      • Diagnostic tests
      • Treatment of myeloma
      • Myeloma symptoms and treatment side-effects
      • Caring for yourself
      • Dealing with the psycho-social aspects of the disease
      • Managing myeloma and work, finance and advance decisions
      • Myeloma landscape and future directions
      • Clinical trials
      • Finding out about myeloma clinical trials
    • About AL amyloidosis
      • Symptoms of AL amyloidosis
      • AL amyloidosis diagnosis
      • Diagnosis challenges
      • AL amyloidosis treatment
      • Living with AL amyloidosis
      • AL amyloidosis: caring for yourself
      • AL amyloidosis treatment side effects
      • Socio-economical impact
      • Advance decisions
      • Novel treatment options in AL amyloidosis
      • AL amyloidosis clinical trials
  • What we do
    • Member and patient community programmes
      • MPE Masterclass
      • Scholarship programme
      • Myeloma CABs
      • MPE Myeloma and AL amyloidosis Community Taskforce
      • Advocate Development Programme
      • COVID-19
      • Reasonable Agreements between Patient Advocates and Pharmaceutical Companies (RAPP)
    • Research
      • Patient Evidence
      • Horizon Europe
        • MMPredict
        • CARAMBA
      • IMI
        • Harmony
        • Sisaqol
    • Access
      • Access to myeloma treatment
      • CEE workgroup on Access
      • Myeloma and AL Amyloidosis Trial Navigator
  • Educational resources
    • Educational clips
    • Webinars
    • Q&As
    • Toolkits
    • Factsheets
    • Conference reports
    • Patient guides
  • News
  • European Myeloma Day
    • European Myeloma Day | Learn
    • European Myeloma Day | Share
    • European Myeloma Day | Change
    • Myeloma infographics
    • AL amyloidosis infographics
    • Videos

Daily Archives: December 10, 2019

You are here:
  1. Home
  2. 2019
  3. December
  4. 10

ASH 2019 myeloma highlights

Conferences, MPE, Myeloma, VideosBy Ana VallejoDecember 10, 2019Leave a comment

More than 900 myeloma abstracts (posters and oral sessions) were presented in the largest world congress of hematology: the American Society of Hematology (ASH) Annual Meeting 2019 that was held from 7 to 10 December 2019 in Orlando, Florida, USA. Dr Faith Davies, NYU Langone Hospital, New York, USA, summarises in this video the most important myeloma updates presented at ASH 2019.

Positive results of the clinical trial Candor at ASH 2019

Conferences, MyelomaBy Ana VallejoDecember 10, 2019Leave a comment

  ASH 2019 – Orlando. The big “late-breaking” news at the American Society of Hematology Annual Meeting are the results of the phase III Candor trial. Dr Katja Weisel, University Medical Center Hamburg-Eppendorf in Germany, explains for Myeloma Patients Europe (MPE) in this video the main results of this clinical trial.

Myeloma Patients Europe AISBL

Avenue Louise 143/4, 1050 Brussels

Belgium

 

© Myeloma Patients Europe 2023

  • Contact
  • About us
  • Privacy Policy
  • Terms and conditions
  • Cookies Policy

  • facebook
  •  
  • twitter
  •  
  • youtube
  •  
  • linkedin
Go to Top